Abstract:BACKGROUND:ERBB3 binding protein 1 (EBP1) gene transfer into human salivary adenoid cystic carcinoma cells has been shown to significantly inhibit cell proliferation and reduce tumor metastasis in mouse models. In the current study, to evaluate if EBP1 is a novel biomarker capable of identifying patients at higher risk of disease progression and recurrence, we examined the EBP1 expression profile in adenoid cystic carcinoma (ACC) patients and analyzed its clinicopathological relevance. To understand the underlying anti-metastatic mechanism, we investigated if EBP1 regulates invasion-related molecules.METHODS:We performed immunohistochemical analysis on 132 primary adenoid cystic carcinoma and adjacent non-cancerous tissues using commercial EBP1, MMP9, E-cadherin and ICAM-1 antibodies. Results were correlated to clinicopathological parameters, long-term survival and invasion-related molecules by statistical analysis. Cell motility and invasiveness of vector or wild-type EBP1-transfected ACC-M cell lines were evaluated using wound healing and Boyden chamber assays. MMP9, E-cadherin and ICAM-1 proteins in these cell lines were detected using western blot assay.RESULTS:The expression of EBP1 was significantly higher in non-cancerous adjacent tissues compared with corresponding cancer tissues. The intensity and percentage of cells that reacted with EBP1 antibodies were significantly higher in cases with tubular pattern than those with solid pattern (P<0.0001). We also found adenoid cystic carcinoma with local lymphatic metastasis had significantly lower EBP1 expression than ACC with no local lymphatic node metastasis (P<0.0001). Similar findings were observed in ACC with lung metastasis compared with cases with no lung metastasis (P<0.0001), in particular, in cases with perineural invasion compared with cases with no perineural invasion (P<0.0001). Furthermore, a decrease in EBP1 expression was positively associated with a reduction in overall survival of ACC patients. Of note, EBP1 inhibits migration and invasiveness of ACC cells by upregulating E-cadherin but downregulating MMP9. In clinical adenoid cystic carcinoma patients, higher EBP1 expression was positively correlated with E-cadherin levels (P<0.001) but negatively correlated with MMP9 expression (P=0.0002).CONCLUSIONS:EBP1 expression is reduced in adenoid cystic carcinoma, indicating unfavorable prognosis of ACC patients. Its regulation of MMP9 and E-cadherin protein levels suggests a critical therapeutic potential.

Analysis of Ac3-33 Gene Expression in Multiple Organ Cancer and Adjacent Normal Tissue by Rna in Situ Hybridization

Downregulation of enhancer RNA AC003092.1 is associated with poor prognosis in kidney renal clear cell carcinoma

Identification of ACBD3 As a New Molecular Biomarker in Pan-Cancers Through Bioinformatic Analysis: a Preclinical Study

[Molecular Cloning and Preliminary Function Study of a Novel Human Gene AC3-33 Related to Suppress AP-1 Activity].

Identiﬁcation and Functional Analysis of a Novel Splice Variant of AC3‑33 in Breast Cancer

Study of the Expression and Function of ACY1 in Patients with Colorectal Cancer.

AC133 expression associated with poor prognosis in stage II colorectal cancer

Comprehensive pan-cancer analysis of ACSS3 as a biomarker for prognosis and immunotherapy response

Genome-wide RNA-sequencing dataset reveals AC096751.1 sever as a novel prognostic long non-coding RNA and its potential molecular mechanisms in patients with colon adenocarcinoma

ACBD3 is up-regulated in gastric cancer and promotes cell cycle G1-to-S transition in an AKT-dependent manner

Increased expression of apoptosis-related protein 3 is highly associated with tumorigenesis and progression of cervical squamous cell carcinoma.

Tumor suppressor ACER1 correlates with prognosis and Immune Infiltration in head and neck squamous cell carcinoma

Systematic Expression Analysis of the CELSR Family Reveals the Importance of CELSR3 in Human Lung Adenocarcinoma.

Expression of ERBB3 Binding Protein 1 (EBP1) in Salivary Adenoid Cystic Carcinoma and Its Clinicopathological Relevance.

Expression profiling of long noncoding RNA identifies lnc-MMP3-1 as a prognostic biomarker in external auditory canal squamous cell carcinoma.

Analysis of the Upregulated Expression Mechanism of Apoptotic Chromatin Condensation Inducer 1 in Hepatocellular Carcinoma Based on Bioinformatics

Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.

Epithelial but Not Stromal Expression of Collagen Alpha-1(Iii) is a Diagnostic and Prognostic Indicator of Colorectal Carcinoma

Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression

High Expression of PRSS3 Indicates Unfavorable Clinical Outcomes in Colon Adenocarcinoma

Acer3 Supports Development of Acute Myeloid Leukemia